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Cervical cancer is the last stage of a series of molecular and cellular alterations initiated with Human 
Papillomavirus (HPV) infection. The process involves immune responses and evasion mechanisms, 
which culminates with tolerance toward tumor antigens. Our objective was to understand local and 
systemic changes in the interactions between HPV associated cervical lesions and the immune system 
as lesions progress to cancer. Locally, we observed higher cervical leukocyte infiltrate, reflected 
by the increase in the frequency of T lymphocytes, neutrophils and M2 macrophages, in cancer 
patients. We observed a strong negative correlation between the frequency of neutrophils and T cells 
in precursor and cancer samples, but not cervicitis. In 3D tumor cell cultures, neutrophils inhibited 
T cell activity, displayed longer viability and longer CD16 expression half-life than neat neutrophil 
cultures. Systemically, we observed higher plasma G-CSF concentration, higher frequency of immature 
low density neutrophils, and tolerogenic monocyte derived dendritic cells, MoDCs, also in cancer 
patients. Interestingly, there was a negative correlation between T cell activation by MoDCs and G-CSF 
concentration in the plasma. Our results indicate that neutrophils and G-CSF may be part of the immune 
escape mechanisms triggered by cervical cancer cells, locally and systemically, respectively.
Cervical cancer is the fourth most common cancer in women worldwide and, according to the World Health 
Organization (WHO) responsible for 7.5% of women’s death by cancer. HPV infection is the main etiological 
factor for cervical cancer development1. After HPV infection, the natural history of cervical cancer is long and, 
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in general, develops through low and high grade cervical intraepithelial neoplasia (CIN) and finally cancer. The 
lower female genital tract has a diffuse lymphoid tissue, prepared to respond to potential injuries and infec-
tions2. The cervix is anatomically more susceptible to HPV infection, which promotes immune responses from 
the infected cells and innate immune cells, as well as adaptive immune responses. It is well known that CD4Th1 
cells respond to viral antigens secreting IFNγ, TNFα and IL-2 and that CD8 T cells can promote wart and lesion 
regression in humans3–5. Moreover, immunosuppressed patients are at higher risk of infection by HPV and lesion 
development6, indicating that the immune system is important in preventing lesion progression and promoting 
infection clearance. Although immune responses against HPV may be robust, there are regulatory and evasion 
mechanisms that can inhibit T cell responses. For instance, in cancer patients, regulatory T cells play an important 
role in the suppression of anti-tumor immune responses7, 8. There is also a positive correlation between mac-
rophage infiltration and lesion grade in the infected cervical tissues9–11. M2 or alternatively activated macrophages 
have been shown to promote angiogenesis, resistance to chemotherapy and suppression of T cell responses in 
cervical cancer patients12–14. Tumors also cause systemic effects on the immune system. Recently, leukocytosis 
has been shown to be a poor prognostic factor for patients with recurrent cervical cancer, as well as a marker 
for resistance to chemotherapy15. The circulating neutrophil/lymphocyte ratio (NLR) has been used as a cancer 
prognostic marker. In patients with cervical cancer, high NLR indicates poor prognostic and resistance to chemo 
and radiotherapy16.
However, the interaction between the various leukocyte populations infiltrating cervical lesions and the sys-
temic effects of these lesions on the immune system are not so well characterized, mainly if we look at precursor 
lesions compared to cancer. The objective of this study was to characterize the inflammatory infiltrate in low and 
high grade CIN and cervical cancer, compared to cervicitis, a non-neoplasic cervical inflammation, which can be 
caused by different etiological factors. We have also investigated cervical lesions systemic effects, such as G-CSF 
plasma concentration, frequency of circulating immature neutrophils and different populations of dendritic cells 
and antigen presentation potential of monocyte derived dendritic cells (MoDC), since these are factors commonly 
associated with cancer tolerance mechanisms in both cervical cancer patients and other cancer patients15, 16.
Results
Increase in the frequency of T lymphocytes, neutrophils and M2 macrophages in cancer sam-
ples compared to precursor cervical lesions. Although HPV infection triggers immune responses, a 
fraction of the infected women are persistently infected and eventually develop cervical cancer. The importance of 
the immune system in clearing the infection is clear6. However, how different leukocyte populations interact with 
each other and the microenvironment throughout lesion progression is not so well understood. Therefore, we 
sought to characterize the global leukocyte infiltrate in samples of cervicitis, CIN 1, 2 and 3, and invasive cervical 
cancer (ICC) by flow cytometry, which allowed us to study several leukocyte populations simultaneously. Our 
patients were recruited through the Gynecology service at Hospital das Clínicas in São Paulo, to which they were 
referred after being diagnosed with positive cytology for HPV associated cervical lesions in their local medical 
services.
Table 1 shows this study’s demographic data and Fig. 1 shows an organogram of patients’ enrolment and num-
ber of cervical samples used. We harvested biopsies from a total of 143 patients. However, we were able to actually 
analyze and use the data correspondent to 88 biopsies. The main cause for discarding part of the biopsies was the 
low yield in cell number or viability after biopsy processing. Also, in a few cases, we were unable to retrieve essen-
tial clinical data from the patients, and therefore, could not use the results from them.
As expected, we observed that ICC patients were significantly older than patients with precursor cervical 
lesions or cervicitis17. Other factors as parity, menopause and smoking habits did not vary significantly among the 
different groups, probably due to the number of subjects in each group. HPV DNA was detected in samples from 
all the groups, although in different frequencies. As expected, a positive correlation between frequency of high 
oncogenic risk HPV infection and lesion grade was observed in our cohort (Table 1). However, the frequency 
of HPV infection in cervicitis patients (78%) was higher than expected. This was probably due to our cohort 
design that recruited patients with indication of altered cytology. It is likely that in the average six months period, 
between cytology diagnostic and visit to the Gynecology service at Hospital das Clínicas, part of the patients 
spontaneously eliminated their lesions, though not the HPV infection.
Single cell suspensions obtained from colposcopy driven biopsies, with 90% or more viable cells, were labeled 
with antibodies against several leukocyte cell surface markers and analyzed by flow cytometry (Supplementary 
Information 1a,b). As can be observed in Fig. 2, there was some spread in the leukocyte frequency of our samples. 
In order to facilitate data analyzes, we opted to show the frequency of specific leukocyte populations within the 
gate that defined the CD45+ pan-leukocyte one. We observed that the global leukocyte infiltration (CD45+ cells) 
was significantly higher in ICC than in CIN lesions and cervicitis (Fig. 2a,c). This increase was due to the increase 
in T lymphocytes (SSClowCD45+CD3+CD19−), neutrophils (SSChighCD45+CD16+HLA-II−CD11b+CD86−) and 
M2 macrophages (CD45+CD3−CD11b+CD16+HLA-DR+CD64+CD86+CD206+, population defined by positive 
CD206 expression18) frequencies. One can notice that the frequency of these populations was unchanged within 
the CD45+ population, indicating they varied accordingly to the parental CD45+ population, therefore, increas-
ing in cancer samples. On the other hand, we observed that within the CD45+ population, the frequency of NK 
(SSClowCD3−CD16+) cells and M1 macrophages (CD45+CD3−CD11b+CD16+HLA-DR+CD64+CD86+CD206−) 
was significantly lower in cancer samples than in precursor lesions. Together, M1 macrophages and NK cells 
accounted for 6.3, 5.2, 5.6, 4.6 and 2.9 percent of the total leukocyte population in cervicitis, CIN1, 2, and 3 and 
cervical cancer biopsies, respectively (Fig. 2c). Therefore, in average and in comparison to the other leukocyte 
populations infiltrating the cervical lesions, there was a relative decrease of 2.17 fold in M1 and NK combined 
populations in cancer when compared to cervicitis and 1.77 fold in relation to CIN lesions. These results suggest a 
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change in the cervical microenvironment as lesions progression from low and high grade intraepithelial neoplasia 
to cancer.
We have detected infiltrating B lymphocytes in a percentage, but not all of the cervical lesions (Fig. 2a,b). 
We also investigated the T cell subpopulations CD4 and CD8 (SSClowCD45+CD19−CD3+CD4+CD8− and 
SSClowCD45+CD19−CD3+CD4−CD8+, respectively) but found that they varied according to the T cell total pop-
ulation (data not shown). Finally, we did not find a Lin−CD11b+CD33+ population in our biopsies, which would 
correspond to myeloid derived suppressor cells (MDSC)19, nor did neutrophils express CD33 (Lin corresponds 
to lineage markers, used to gate out lymphocytes, granulocytes and monocytes from the cytometry analysis).
Our flow cytometry data was confirmed by histopathological analyzes of hematoxylin/eosin (HE) stained cer-
vical biopsies. We could observe monocytic (black arrows, pointing to lymphocytes and macrophages) and poly-
morphonuclear cells infiltrating in the biopsies (white arrows) (Fig. 2c). Although not by any means quantitative, 
there was a good correlation between the flow cytometry and histology data, regarding the total inflammatory 
infiltration (Fig. 2c,ii) in the cervical lesions, as well the infiltration by monocytic and polymorphonuclear cells 
(Fig. 2c). Importantly, in very few biopsies we found extensive hemorrhagic areas, so that the leukocytes detected 
by flow cytometry were the result of active recruitment, rather than blood vessels disruption.
Infection by other pathogens may have a role in leukocyte recruitment to the cervix. Data from patients’ files 
indicated, in a few cases, other microbial infections besides HPV. We found indication of infection by Gardnerella 
or cocci in a total of 10 patients, in the cervicitis and CIN1 groups, and Chlamydia infection in a CIN3 sample. We 
have compared the leukocyte infiltrate in biopsies from patients with and without indication of bacterial infection 
and found no significant differences (data not shown).
Negative correlation between T cells and neutrophils differentiated CINs and cancer from cer-
vicitis. T lymphocytes and neutrophils were the most abundant cells in the leukocyte infiltrate of the cervical 
lesions. Their frequencies varied among patients, ranging from 11.8 to 82.8 percent of CD45+ population, for T 
cells, and 1 to 69 percent for neutrophils. In cervical cancer patients, the circulating NLR has been used as prog-
nostic marker16. We asked whether there was any correlation between neutrophils and T cells in the cervix. As can 
be observed in Fig. 3a, there was a strong and significant negative correlation between neutrophils and T cells in 
all CIN lesions and ICC, but not in cervicitis. To further understand the interaction between neutrophils and T 
cells, we repeated this analyzes separating T cells in CD4 or CD8 subpopulations. Significant negative correlation 
was observed in CIN3 and in ICC, although the last one only with CD8 T cells (Fig. 3b). We were not able to per-
form these analyses with CIN1and CIN2 samples (due to the smaller number of cells obtained from these sam-
ples, we excluded analyses of CD4 and CD8 subpopulations in approximately 40% of these biopsies, and therefore 
did not have enough events for correlation analysis). The strong negative correlation between T cells and neutro-
phils led us to question whether neutrophils could inhibit T cells in the lesion microenvironment20. We proceeded 
to perform in vitro assays to verify this possibility. We also raised follow up information from the patients enrolled 
in the study. Although our follow up period is short, we did obtain data from a few patients and, interestingly, 
Figure 1. Organogram of cohort enrolment. Patients with cytology indicative of HPV associated lesion 
were referred to Hospital das Clínicas. A total of 143 patients were enrolled with colposcopy suspicious of 
cervical lesion. Biopsies and peripheral blood were processed and if we obtained enough cells from biopsies, 
these cells were labeled with antibodies to continue the study, if not, only the blood sample was saved. From 
the 62 discarded biopsies, 54 did not have enough cells; the others were discarded because there was not 
enough patient’s clinical data. Several of the harvested and analyzed samples were reclassified according to the 
histopathological classification determined by the Pathology service at Hospital das Clínicas. This meant that 
flow cytometry analyses were performed as blind assays regarding lesion grade, which avoided any kind of bias 
by the student conducting the experiments. In the end of the enrolment period, we had 81 analyzed biopsies 
distributed in different lesion grades as indicated in the figure.
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we found that in patients with persistent or recurrent lesions, the T lymphocyte/neutrophil frequency ratio was 
bellow 8. In other patients free of disease, we found varying T cell/neutrophil ratios (Fig. 3c). Although we need a 
longer follow up period and larger sample to be able to confirm this data, it seems that recurrent lesions are more 
likely to be observed in patients with lower T lymphocyte/neutrophil frequency local ratios.
Figure 2. Leukocyte populations infiltrating cervical lesions. (a) Flow cytometry analyses of cervical single cell 
suspensions labeled with antibodies against cell surface markers. Total infiltrate corresponds to all CD45+ cells 
(box plot left side), all other box-plots are cells gated in the CD45+ population. Phenotype of each population is 
specified in Supplemental Material 1. Number of patients in each group is specified in Fig. 1. (b) Frequency of 
different cell populations per patient group. The values correspond the average frequency of each population; 
standard deviation values were omitted in the sake of space. Populations’ frequencies were compared by one-way 
ANOVA, *indicates significant differences in cells frequency among groups. (c) Histology of cervical tissues stained 
with HE. Image magnification is indicated, as well as lesion grade. E – epithelial compartment, ii – inflammatory 
infiltrate, * - glandular tissue, § - blood vessels, black arrows point to mononuclear cells, white arrows point to 
granulocytes. CC – cervicitis, CIN 1, 2, 3 – Cervical Intraepithelial Neoplasia grades 1, 2, 3, ICC – invasive cervical 
cancer. Scale bars indicate 250 μm and 50 μm in 40X and 1000X magnification micrographs (upper panels), 
respectively.
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Neutrophils in cervical biopsies display markers of suppressive neutrophils. Based on the 
hypothesis that CIN infiltrating neutrophils could inhibit T cell responses, we first decided to evaluate activation 
markers in the cells present in the cancer biopsies, compared to circulating neutrophils. Our first observation was 
that neutrophils from cancer biopsies expressed significantly lower levels of CD16 (FcγR III) than neutrophils 
from precursor lesions (Fig. 4a). In spite of that, CD16 and CD66b expression levels were significantly higher in 
neutrophils from biopsies than circulating neutrophils from the same patients (Fig. 4b). Interestingly, biopsy neu-
trophils expressed low CD62L levels (Fig. 4b). CD16 can signal through Phosphatidylinositol-3 kinase (PI3K) in 
neutrophils leading to cell activation and increased survival21. CD66b, likewise, is a neutrophil activation marker, 
but may also indicate immunosuppressive activity22. Moreover, CD16highCD62Ldim neutrophils are recognized as 
suppressive neutrophils, with low ROS production capacity and suppression of T cell activity23, 24. Therefore, our 
results added to our hypothesis that neutrophils in cervical cancer could be suppressive neutrophils.
Figure 3. Negative correlation between neutrophils and T cells in CIN and ICC. (a) Frequencies of T cells 
and neutrophils in each cohort group were compared by Pearson correlation. Number of samples per group 
is described in Fig. 1. (b) Comparison between CD4 and CD8 and neutrophil frequencies in CIN3 and ICC 
samples by Pearson correlation. There were 9 CIN3 biopsies and 11 ICC biopsies in these analyses. The graphs 
indicate the R values and p values (significance) for each correlation. (c) T cell/neutrophil frequency ratio 
in patients with CIN1, 2 and 3 free of disease (−) or with persistent or recurrent disease (+) after excision 
procedure. Follow up period varies between 1 and 3 years.
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Figure 4. Characteristics of cervical cancer infiltrating neutrophils. (a) CD16 expression (median fluorescence 
intensity, MFI) was evaluated in biopsy neutrophils, after collagenase digestion, labeling with anti-CD33, 
CD66b, CD11c, CD15, CD11b, CD45, CD62L, and analyzed by flow cytometry. After exclusion of debris 
and doublets, by SSC-A x FSC-A and FCS-A x FSC-H, cells gated on high SSC and CD45+ were evaluated 
for expression of the indicated makers. The only marker with significant changes among patient groups was 
CD16. As we had few CIN2 patients to evaluate for this parameter, we joined these patients with CIN3 patients 
to form a high grade lesion group (HG). CC – cervicitis, LG – low grade lesion group (same as CIN1), ICC – 
invasive cervical cancer. We evaluated 11 CC patients, 10 LG patients (same as CIN1), 12 HG patients and 15 
ICC patients. The indicated p value, was obtained with one-way ANOVA testing. (b) Comparison of CD16, 
CD66b and CD62L expression in biopsy and circulating neutrophils (PB) from ICC patients. Results are 
displayed as median fluorescence intensity (MFI) and in this case, compared by t-test. The resulting p values are 
indicated. (c) ROS production by biopsy and circulating neutrophils from ICC patients, measured by DHR123 
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To test the activity of cervical cancer neutrophils, we sorted and activated neutrophils from blood or ICC biop-
sies (number of cells recovered from CIN did not allow us to perform this type of assay with other lesions) and 
stimulated with 12-O-Tetradecanoylphorbol-13-acetate (TPA) ex vivo. Neutrophils from ICC were able to gen-
erate similar concentrations of reactive oxygen species (ROS) as circulating neutrophils from the same patients 
upon stimulation (Fig. 4c). Therefore, neutrophils from cancer biopsies were alive and functional, able to activate 
NADPH oxidase upon stimulation.
We decided to further investigate the effect of tumor cells on neutrophils by using an experimental model with 
SiHa and HeLa tumor spheroids (HPV16 squamous cell carcinoma and HPV18 adenocarcinoma derived cell 
lines, respectively. These are the most common HPV types in cervical cancer patients)25. Circulating neutrophils 
from healthy donors were incubated alone or with SiHa or HeLa spheroids for 4, 8 and 24 hours. We observed, 
as shown in Fig. 5a, that after 24 hours of culture, there was a significant higher percentage of live neutrophils in 
co-cultures, than in neat neutrophil cultures (1.56 and 1.4 fold more live neutrophils in co-cultures, respectively). 
We also observed that CD16 expression half-life was significantly shorter in neat neutrophil cultures than in 
neutrophils in co-culture with SiHa or HeLa cells (Fig. 5b,c), which could be the cause for the extended half-life 
of these cells in co-culture with tumor cells21. CD66b expression had no significant alteration between the two 
experimental groups (Fig. 5b,c). Interestingly, in the cervical biopsies, we also did not observe significant altera-
tion of CD66b expression among the different lesion grades, indicating that this molecule was upregulated upon 
recruitment, but not modulated by the cervical cells.
Tissue processing could activate neutrophils. Therefore, we processed circulating neutrophils in the exact 
same way as cells from biopsies and observed that several surface markers were up regulated: CD11c, CD62L, 
CD45, CD11b. CD66b was marginally activated by manipulation (1.3 fold), and CD16 expression was not altered 
(data not shown), again indicating that CD16 expression was modulated by tumor cells.
Finally, we also observed a 7.7 fold increase in IL-6 secretion in SiHa and neutrophils co-cultures compared 
with SiHa cell cultures, after 24 hours incubation. IL-8 was expressed by neutrophils alone and there was no sig-
nificant increase in its secretion by co-culture with SiHa (Fig. 5d). We also investigated expression of IL-1β, IL-10, 
IL-12 and TNFα, and found no expression of these cytokines in these cultures.
Neutrophils controlled T cell activity. In cancer, neutrophils have been shown to display both pro and 
anti-tumoral effects20. Inhibition of T cell activity is one of the mechanisms by which they may facilitate tumor 
growth. Our previous results indicated that neutrophils from cervical cancer might display a suppressive phe-
notype. To test this hypothesis, we used SiHa tumor spheroids to test the interaction between neutrophils and T 
cells in a tumor like microenvironment. In these experiments, CellTrace labeled T cells were stimulated ex vivo, 
washed and then added to a co-culture of neutrophils and SiHa spheroids. Four days later, we harvested the cells 
and labeled with antibodies for flow cytometry analysis. To mimic what we observed in the cervical biopsies, 
we set up cultures with 1:1 or 10:1 T cells/neutrophils ratios. Tumor cells did not inhibit T cell activity. On the 
contrary, T cells proliferated, expressed activation markers, secreted IFNγ and even eliminated tumor cells in the 
spheroids (Fig. 6a–c). However, when incubated with neutrophils, in 1:1 proportion, T cells were inhibited. We 
observed significant decrease in T cell proliferation, expression of CD69, mainly in CD4 T cells, and expression 
of CD25 in both CD4 and CD8 T cells (such low CD25 expression may be indicative of failure to proliferate upon 
mitogen stimulation). We also observed inhibition of IFNγ secretion. On the other hand, we observed mainte-
nance of SiHa cells in the cultures (Fig. 6b,c). Therefore, although T cells were functional in the presence of tumor 
cells, they were inhibited by the addition of neutrophils. This effect was almost completely lost if we seeded 10 T 
cells to 1 neutrophil, indicating that in excess, T cells were resistant to neutrophils inhibitory effects. One can 
also observe that neutrophils alone could inhibit proliferation of T cells and IFNγ secretion, when in 1:1 culture 
ratio. However, this effect was probably mediated by the release of toxic molecules upon death of the neutrophils.
Our conclusion from these experiments was that in high frequency, neutrophils in the tumor microenviron-
ment could inhibit T cells activity.
Systemic effects were observed in cancer patients, where there was higher concentration of 
circulating G-CSF, CD66b+ immature neutrophils and lower antigen presenting potential. Our 
laboratory has previously shown, using experimental models, that HPV positive tumor cells expressed different 
cytokines in vivo, including G-CSF, IL-6 and IL-826, 27. Others have shown that patients with cervical cancer have 
high circulating G-CSF concentration and leukocytosis28. G-CSF induces neutrophil ontogeny, mobilization from 
the bone marrow, recruitment and viability29. Moreover, G-CSF and IL-6 may promote expansion of myeloid 
derived suppressor cells, which can interfere with T cell activation and anti-tumor responses.
We wanted to study potential systemic effects of cervical lesions on the immune system of the patients, and 
also determine at which point in lesion progression we would be able to detect these alterations. We focused on 
parameters previously associated with worse prognosis in cervical cancer patients, as G-CSF concentration, or in 
cancer in general, as monocyte derived dendritic cells decreased antigen presentation potential.
We observed that our ICC patients had the highest G-CSF circulating levels, although patients with CIN2 and 
CIN3 also had higher levels of circulating G-CSF concentration than patients with CIN1, cervicitis or controls 
fluorescence. Neutrophils isolated from biopsies or peripheral blood were stimulated with 100 ng/ml TPA for 
15 min and then incubated with DHR-123 for 15 min. Cells were then labeled with anti-CD45, CD11b and 
CD66b. DHR signal, displayed as median fluorescence intensity (MFI), was measured in triple positive cells, 
after gating out debris and doublets. In this case, our experimental group had 5 patients. Results were tested by 
t-test between control and treated cells, and the p values are indicated. There was no difference between ROS 
production in control or treated neutrophils from biopsies compared to circulating cells.
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Figure 5. Cross-talk between cervical cancer derived cells and neutrophils. Neutrophils in co-culture with SiHa 
spheroids (co-culture) or in pure cultures (neutrophils) were evaluated at the indicated periods of time for: (a) 
viability, (b) CD66b and CD16 expression, and (c) cytokine production (only at 24 hours of culture). At each 
time point, cells and supernatants were harvested, cells were labeled with anti-CD45, CD66b, CD16, fixed and 
incubated with 10 μg/ml DAPI for 30 min before flow cytometry analysis. A. DAPI fluorescence was measured 
in the CD45+ population. The gated cells in the histograms indicate DNA content corresponded to whole 
cells, events to the left, correspond to sub-G1 dead cells. Significant differences were found only at 24 hours 
of culture (p value indicated). Still within the CD45+ population, we evaluated frequency (b) and expression 
ratio (c), depicted as expression of CD66b and CD16 in co-cultures/expression in pure neutrophil cultures. The 
frequency plots are representative of one experiment, and the kinetic in the right side graphs are the average 
ratios obtained from all experiments. A total of 5 different blood samples were used in these experiments. 
The U-test Mann Whitney tested differences in CD16 and CD66b expression ratios through time; *indicates 
significant differences in CD16 expression between experimental conditions; dotted lines indicate ratio 1 for 
reference. (d) Cytokine production. Supernatants from 24 hours cultures were tested for cytokine production 
using the Human Inflammatory CBA kit, according to the manufacture’s instructions. Although this kit has 
antibodies for several cytokines, only IL-6 and IL-8 were secreted in concentrations above cut off values. SiHa –  
tumor cells spheroid supernatant, Neu. – neutrophils supernatant, S/N – SiHa spheroids and neutrophil co-
cultures. We tested the results using one-way ANOVA, *indicates significant differences between experimental 
groups.
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with no reported cervical lesion (Fig. 7A). Therefore, our data indicated that G-CSF concentration increased with 
lesion grade and we could detect this event before other systemic events and alterations in the local microenvi-
ronment were noticeable, at least as far as we were able to measure.
Figure 6. Effects of neutrophils over T cell activity in a tumor-like environment. Cell proliferation dye labeled 
T cells were stimulated with 100 ng/ml TPA and 1 μg/ml ionomycin (TPA/Iono) for 5 hours, before they were 
washed and added to neutrophils cultures (in 1 T cell: 1 neutrophil or 10 T cells: 1 neutrophil ratios), or 4 
days SiHa spheroid cultures (SiHa) or neutrophils previously incubated for 5 hours with 4 days SiHa spheroid 
cultures. After 5 days incubation, cells were harvested and labeled with anti-CD45, CD4, CD8, CD25, CD69, 
fixed, and labeled with 10 μg/ml DAPI and then analyzed by flow cytometry. (a) For proliferation analysis, we 
gated out debris and doublets, than gated on CD45+ cells and then CD4+ or CD8+ cells, where we evaluated 
the percentage of cells that had low Cell Proliferation dye fluorescence, compared to a non-stimulated T cell 
control. Experiment representative of 4 independent ones (there was variation among cells from different 
donors). Numbers indicated in the graph, show the average of the proliferation ratios between T cells in 1:1 
and 1:10 cultures with neutrophils incubated with SiHa spheroids in 4 independent experiments. (b) Relative 
CD25 and CD69 expression in the same cultures described in (a), as well as concentration of IFNγ in the 
cultures supernatant measured with the CBA kit (BD Biosciences). Results are the average of 4 independent 
experiments, and were tested by one-way ANOVA, either comparing 1:1 culture conditions and 1:10 culture 
conditions; *indicates significant differences between experimental groups, dotted lines indicate ratio 1. (c) 
Depletion of SiHa cells from cultures with 10:1 T cells/neutrophils. Dot-plots on top represent the SiHa cells 
gate obtained after cells harvesting and flow cytometry analyzes. Total absolute cell numbers were determined 
by counting cells suspensions using a hemocytometer. These numbers were multiplied by the frequency of SiHa 
cells to obtain the absolute SiHa numbers per experimental condition. The graph bellow shows the ratio of 
SiHa cell numbers in SiHa/T cells cultures (TS) divided by the SiHa cell numbers in SiHa/neutrophils/ T cells 
cultures (TSN) in the different T cell/neutrophil experimental ratios. Results are the average of 3 independent 
experiments, tested by t-test, p value indicated in the graph, dotted lines indicate ratio 1.
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Figure 7. Cervical lesion systemic effects. (A) G-CSF plasma concentrations, measured by ELISA. We used 
plasma from 8 control donors, from 10 CC patients, 8 CIN1, 11 CIN2, 18 CIN3 and 17 ICC patients. Results 
were compared by one-way ANOVA, significant differences are indicated by *. (B) Frequency of immature 
circulating neutrophils. The mononuclear cells from the Ficoll-Paque gradient were harvested and labeled with 
anti-CD66b and CD11b. The graph shows the frequency of CD66b+CD11b− cells in each experimental group, 
which contained 5 controls, 4 CC patients, 13 high grade lesion patients (HG) and 11 ICC patients. We had only 
2 patients with CIN1 lesions, therefore, had to exclude this group from this analysis. Again, results were tested 
with one-way ANOVA, and the p value is indicated. (C) Correlation between G-CSF plasma concentration 
and frequency of circulating immature neutrophils CD66b+. We used Pearson correlation to compare these 
parameters, R values indicated in each graph. (D) Allogeneic T cell stimulation. Cell proliferation dye labeled 
T cells from control donors were incubated for 4 days with MoDCs from patients of the indicated groups. 
After incubation, cells were harvested, labeled with CD4, CD8 and CD25 and analyzed by flow cytometry. 
Cell proliferation data shows the frequency of cells within the CD4+ or CD8+ T populations that diluted the 
proliferation dye, therefore, that proliferated during the experiments. CD25 expression, represented as median 
fluorescence intensity (MFI) was gated on CD4 T cells. We used one-way ANOVA to compare experimental 
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We observed that cancer patients had higher numbers of circulating low density CD11b−CD66b+ cells, which 
correspond to immature neutrophils30, 31 (Fig. 7B). Correlation between plasma G-CSF concentration and fre-
quency of circulating CD11b−CD66b+ cells from the same patients showed us that, while there was no correlation 
between these parameters in patients with cervicitis or high grade CIN, there was a moderate positive correlation 
between these two parameters in patients with cancer (Fig. 7C), indicating that this cytokine may have a role in 
the accumulation of these cells in the blood of cancer patients. Unfortunately, we did not have enough patients 
with samples to perform a correlation test with the low grade CIN group.
G-CSF can modulate dendritic cells differentiated from monocytes (MoDC), inducing a tolerogenic pheno-
type29. Allogeneic antigen presentation assays using MoDC from our patients and T lymphocytes from healthy 
donors showed us that monocytes from cancer patients originated tolerogenic dendritic cells, which inhibited 
T cell proliferation and induced CD25 expression, which high expression may indicate regulatory phenotype 
(Fig. 7D). Again, we could compare G-CSF plasma concentrations with T cell proliferation induced by MoDCs 
of some of our patients. We found that there was no correlation between these parameters in patients with low 
grade lesions. We found, however, a negative correlation between CD4 (R = −0.07, p < 0.05) and CD8 (R = −0.9, 
p = 0.02) proliferation induced by MoDCs and G-CSF plasma concentrations from patients with CIN3 lesions, 
and also negative correlation between CD4 (R = −0.9, p < 0.05) proliferation and G-CSF plasma concentrations 
from ICC patients (Fig. 7E).
Finally, we have investigated the frequency of myeloid (Lin−HLA-DR+CD11c+CD123−) and plasmacytoid 
(Lin−HLA-DR+CD11c−CD123+) circulating dendritic cells in our cohort. We have found no significant differ-
ences in the frequency of these populations in our groups, with averages of 51.8% (DP 6.1%) of CD11c+ and 7.7% 
(DP 1.8%) of CD123+ cells within the Lin−HLA-DR+ PBMC population.
Discussion
This work aimed to characterize changes in the local microenvironment and systemic parameters that could point 
to escape mechanisms that could participate in cervical cancer progression. One of our questions was if it was 
possible to detect alterations in the various measured parameters in precursor lesions. Curiously, although we 
could observe an increase in the pan-leukocyte infiltration in cervical precursor lesions, specific population fre-
quencies changed significantly only in cancer samples. However, we could observe significant increase in G-CSF 
plasma concentration in patients with high grade precursor lesions, indicating that in spite of imperceptible, 
precursor lesions did influence the immune system of the patients systemically.
T cells were the most abundant population in all our samples, followed by neutrophils and macrophages. 
Accordingly, Givan and collaborators found similar frequencies of these populations in the cervix of women 
undergoing hysterectomy32. The increase in leukocyte recruitment in cancer patients may be due to an increase 
in tumor cell numbers and changes in tumor cell secretion profile, which would result in higher concentrations of 
cytokines and chemokines, leading to increased recruitment. Changes in the microbiome also could lead to alter-
ations in the mucosal leukocyte populations. Although we could not determine a correlation between reported 
clinical infection with other agents than HPV and frequency of inflammatory infiltrate in cervical biopsies, we are 
currently sequencing 16 S bacterial DNA from all our samples, hoping to get in depth information about micro-
organisms present in the cervix of our patients.
While T cells, neutrophils and M2 macrophages infiltration increased in cancer samples, the opposite was 
observed with M1 macrophages and NK cells, resulting in relatively lower frequency of the last two populations 
in cervical cancer biopsies in comparison to other cell populations. Interestingly these are two potentially cyto-
toxic populations, which could eliminate tumor cells. The relative decrease in these populations may be due to 
changes in adaptive immune responses in cancer patients: for instance, regulatory T cells can deprive NK cells of 
IL-2 and decrease their activation and proliferation33, and there may be less M1 macrophages differentiation due 
to the lack of Th1 responses. Indeed, our data shows that cancer patients had tolerogenic MoDCs, which could 
lead to reduced T cell responses, and alterations in the tumor microenvironment. Interestingly, although G-CSF 
is known for its role as a growth factor for neutrophils, it can also modulate the activity of MoDCs, inducing a 
tolerogenic phenotype29. Indeed, in patients with cancer or high grade lesions, there was an inverse correlation 
between G-CSF plasma concentrations and T cell activation by MoDCs, suggesting that even precursor lesions 
can modulate systemic immune responses.
Data in the literature indicate that macrophages, the third most abundant population in our samples, display a 
pro-tumoral effect in cervical cancer14. Our laboratory has previously demonstrated, using experimental models, 
that macrophages from HPV associated tumors can suppress T cell anti-tumor activity34. We have thoroughly 
tested macrophage and T cell frequencies correlations and found only weak negative correlations. It is possible 
that because macrophages are less abundant than neutrophils in the cervical lesions, the last may have predomi-
nant effects on T cells, which does not mean that we can rule out potential suppressive effects macrophages may 
also have on T cells. Another factor to consider is that M2 macrophages may promote other important events 
in the tumor microenvironment as angiogenesis and resistance to chemotherapy10, 13, 14. The increase in the fre-
quency of the M2 population, therefore, may have different effects on cervical tumor progression, other than 
supression of immune responses.
groups. In all cases, samples from ICC patients were significantly different from the other patients. CC – 
cervicitis, LG – cells from patients with low grade lesions (or CIN1), HG – cells from patients with high grade 
lesions (CIN2/3), ICC – cells from patients with invasive cervical carcinoma. (E) Pearson correlations between 
T cell proliferation determined in D and plasma G-CSF concentrations, determined in B; R and p values are 
indicated in the plots.
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Neutrophils were the second most abundant population in our samples. Among their effects, neutrophils 
together with tumor cells promoted an IL-6 and IL-8 rich environment. This effect may add to the inefficiency 
of T cell activation, as it has been described that these cytokines can promote accumulation of regulatory T cells 
in mesotheliomas35. Moreover, IL-6 together with PGE2 is known to promote tolerogenic phenotype in antigen 
presenting cells14, again inhibiting T cell activity. It is possible that our cancer patients have higher levels of IL-6 in 
the circulation, as been shown in other cancer patients. However, we have yet to test if this is correct.
All CIN lesions and cancer samples displayed a strong negative correlation between neutrophils and T cells. 
This pattern was not present in cervicitis samples. This data suggests that dysplastic or neoplastic cervical tissue 
controlled the microenvironment in a different manner than inflamed cervical mucosa. In the gynecological 
practice, cytology tests are performed periodically to detect cellular alterations in the cervix and avoid cervical 
cancer progression. In some cases, the results are atypical squamous cells (ASC-US, Atypical squamous cells of 
undetermined significance, and ASC-H, cannot exclude high grade lesion), which bring uncertainty to both the 
patient and physician, and require HPV testing and follow up to try to determine if there is a lesion present and 
which measures to take to avoid cancer progression. It will be interesting to test if it is possible to use the lym-
phocyte/neutrophil ratio in cytology tests to differentiate CIN lesions from other atypical cervical abnormalities.
Tumor associated neutrophils (TAN) may suppress T cell responses36. Using an in vitro model, we could show 
that tumor cells modulated neutrophils incubated with SiHa spheroids, which in turn suppressed T cell prolifera-
tion and activity. How T cells could be eliminating the SiHa cells, we do not know at this point, probably through 
secretion of cytotoxic factors. There is evidence that neutrophils exposed to G-CSF may acquire a tolerogenic 
phenotype, through IL-10 secretion37. This seems not be the case in our system, since we found no IL-10 secretion 
in neutrophil/tumor cells cultures. Other mechanisms by which neutrophils could inhibit T cells are production 
of ROS, expression other cytokines as IL-6, or PD-1L expression20, 38. However, we still need to investigate the 
interaction between tumor cells, neutrophils and T cells to understand the mechanisms behind our observations.
Circulating NLR has been used as prognostic marker for different types of cancer, including cervical cancer16. 
In our study, we found higher frequency of low density CD66b+ cells in the blood, which could eventually infil-
trate the cervix of our patients. Although we have not addressed this issue specifically, as our data is represented 
in percentage of cells, the increase of this population definitely indicates a higher CD66b+/lymphocyte ratio 
in our cancer patients. Interestingly, recent data has shown that a relatively high percentage of cervical cancer 
patients have leukocytosis (14%) and high circulating G-CSF levels, which are poor prognostic markers15, 39, 40. As 
Mabuchi and collaborators observed a correlation between G-CSF concentration and leukocytosis, we identified 
Characteristic Cervicitis CIN1 CIN2 CIN3 Invasive Ca
Number of analyzed 
biopsiesa n = 24 n = 14 n = 25 n = 46 n = 34
Number of analyzed 
blood samplesa,b 8 6 17 14 17
Age (yrs)
median 38 28 36 33 45d
range 24–81 19–67 23–59 21–57 24–75
Parity
mean 2 2 2 2 3
range 0–5 0–4 0–4 0–5 0–11
Sexual debut (yrs)
median 17 18 19 16 16
range 15–20 14–23 14–23 12–24 14–18
Menopause percentage 0 10 18 4 28
Smokers percentage 28 27 18 29 22
HPV infection percentage 78 92 86 95 95
High risk HPV infection percentage 65 83 86 92 95











Table 1. Demographic data from patients enrolled in this study. aIn each experimental group there was a varied 
proportion of patients from whom we were able to analyzed both the cervical biopsy and blood samples; bblood 
samples include PBMCs, neutrophils and plasma, not all samples were analyzed for all different parameters; cthe 
multiple HPV infection group is a percentage of the total analyzed samples, and is included in the HPV positive 
infection group; dthere was a significant positive correlation between age and lesion grade. Patients with cancer 
were significantly older than patients with other lesions (tested by one-way ANOVA, p = 0.03). Invasive Ca – 
invasive carcinoma.
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a positive, although moderate, correlation between G-CSF serum concentration and frequency of low density 
CD66b+ cells in the blood of cervical cancer patients.
G-CSF signals are transduced through the G-CSFR and different signaling pathways, including STAT3 (Signal 
transducer and activator of transcription 3)41. Chronic STAT3 activation has been correlated with tolerance and 
cancer progression41. Therefore, it is possible that the G-CSF/STAT3 axis is controlling part of the systemic and 
local effects we observed in this study. Locally, we can hypothesize that other factors, as IL-6, IL-8 and IL-10, act 
together with G-CSF to influence immune responses. Koshiol and collaborators have shown that women posi-
tive for cervical HPV infection have higher local G-CSF concentration42, supporting our findings. However, it 
is possible that other cytokines secreted in the lesion microenvironment, as IL-6 and IL-10, and that also signal 
through STAT3 may have local and systemic effects, as well, also promoting tolerance. Therefore, it is likely that 
other cytokines and inflammatory factors may also play a role in the control of leukocyte production, recruitment 
and activation. There is actually evidence for the role of IL-10 and IL-6 in promoting tolerance toward HPV 
antigens14, 26.
Our results indicate that as lesions progress from low to high grade to cancer, there is an increase in cytokine 
production, for instance G-CSF, which causes systemic effects that influence the triggering of adaptive immune 
responses, partially inhibiting antigen presentation and therefore T cell activation. Locally these effects cooper-
ate with the accumulation of T cells, neutrophils and M2 macrophages, but decrease of NK cells and M1 mac-
rophages, reflecting a less cytotoxic environment, which again circles back to the diminished T cell activation. 
As far as we now, this is the first comprehensive analyzes of local and systemic effects of cervical lesions on the 
immune system, which may be of importance, not only for addressing cervical cancer treatment, but also may 
help with abnormal cervical cytology diagnosis.
Materials and Methods
Study design. This study was approved by the Institute of Biomedical Sciences Ethics Committee, pro-
cess 1061 and Ethics Committee for research project analyzes of the Hospital das Clínicas, School of Medicine, 
Universidade de São Paulo (National Committee in Research Ethics project 03375412.4.0000.5467). All patients 
and healthy donors signed an informed consent formulary before sample harvesting. All methods followed the 
guidelines established by CONEP, Brazilian National Committee in Research Ethics.
Patients with positive cytology results were referred to the Gynecology ambulatory service of the Hospital das 
Clínicas, School of Medicine, Universidade de São Paulo, Brazil. Two to six months passed between the cytology 
and the exam at the Hospital das Clínicas, so that some of the patients, although still HPV positive, had already 
spontaneously eliminated their lesions. In the Gynecology service, patients were submitted to colposcopic exam-
ination. At the physician discretion, patients were submitted to an excisional procedure or biopsy harvesting for 
diagnostic. In both cases, a second biopsy within the lesion area was taken for our study and immediately placed 
in a tube containing 5 ml of sterile RPMI1640 (LifeTechnologies, Carlsbad, CA). Patients also donated 10 ml of 
peripheral blood. Patients pregnant or with any type of immunosuppression were excluded from study. The study 
was designed to compare samples from 20 patients from each of the groups: cervicitis, CIN1, CIN2, CIN3 and 
invasive cancer. However, after histopathological analyses, some of the samples were re-classified, which led to a 
variation in the number of samples per group. We enrolled a total of 143 patients, but we able to analyze a total 
of 81 biopsies (Fig. 1). Most of the discarded biopsies had insufficient number of cells or low viability after tissue 
digestion; other had insufficient clinical information.
For some experiments, we needed blood cells from healthy donors. We harvested blood from 20 controls, 
with ages ranging from 25 to 50 years old, all with the same exclusion criteria than our patients, and no reported 
cancer. Blood samples were collected in Heparin Vacutainer tubes (Becton-Dickinson, Sunnyvale, CA). Samples 
were processed within 3 to 4 hours after harvesting.
Tissue processing. Cervical biopsies were split in two fragments. The smaller was used for DNA extraction 
and HPV genotyping, the largest one was finely minced and digested with 1 mg/ml Collagenase I and IV in MTH 
(1x Hanks’ buffered salt solution with 15 mM HEPES pH 7.4, 5% Fetal Bovine Serum, FBS, 0.5 U/ml DNAse I) at 
37 °C, 1300 rpm using a Thermomixer (Eppendorf, New York, NY) for approximately 40 minutes. Cells were then 
filtered, washed in MTH and counted with Trypan blue to determine cell number and viability (usually between 
90% and 95%). Contaminant enzymes may digest cells surface markers. The use of FBS in the digestion buffer 
inhibits the potential contaminants, avoiding non-specific digestion43.
Peripheral blood monocytic cells (PBMCs) were isolated from peripheral blood through density gradient 
centrifugation in Ficoll-Paque (GE Life Sciences, Marlborough, MA). Plasma samples were frozen in aliquots for 
later use.
Neutrophils were isolated from peripheral blood, starting with 2 ml of blood, from which we recovered 
1.4 ± 0.28 million CD15+ 44.
Flow cytometry. Cervical cell suspensions were labeled with directly conjugated monoclonal antibodies 
(Supplementary Information 2). All antibodies were tittered to optimal concentration before use. Unstained cells 
were used to define gates for positive labeled. For staining, cells were blocked with 1:100 FcBlock (ThermoFisher, 
Waltham, MA) for 15 min at 4 °C, prior to addition of antibodies and incubation for 20 min at 4 °C. Cells were 
then washed and fixed in buffered 2% paraformaldehyde. All cells were analyzed by flow cytometry, where at least 
5,000 events of the CD45+ population were acquired.
The gating strategy for biopsy analyses was the following: exclusion of debris and doublets, gate on CD45 X 
FSC to identify the leukocyte population, and within this population, we plotted CD45 × SSC to identify 3 CD45+ 
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populations, with high, intermediate and low SSC. Within each of these gates, we analyzed the frequency of differ-
ent populations, using specific antibody cocktails as shown in Supplementary Information 1a,b.
Flow cytometry of blood cells or cell cultures were performed with gating on FCS × SSC for debris exclusion, 
followed by doublet exclusion, and then analyses of the different markers, including cell proliferation dye.
All flow cytometry was acquired in a FACSCanto II (BD Biosciences, San Jose, CA), and data was analyzed 
using the FlowJo software 7.6.5 v (TreeStar, Ashland, OR).
T cell and neutrophil in vitro assays. All cell culture incubations were done in 10% FBS in RPMI1640, at 
37 °C in a 5% CO2 atmosphere.
MoDC differentiation. monocytes were isolated from PBMCs by adhesion to cell culture plates for 12 hours. 
Cells were treated with 50 ng/ml GM-CSF and 50 ng/ml IL-4 (both from PeproTech Inc., Mexico) for 5 days, fol-
lowed by a 48 hours treatment with 50 ng/ml TNFα (PeproTech Inc., Mexico) to induce differentiation and activa-
tion of MoDCs. In the 7th culture day, cells were harvested and counted. An aliquot was taken from a few random 
samples to confirm the DC phenotype (CD11c+CD14−CD86+HLA-DR+) (Supplementary Information 1c). The 
other cells were used for mixed leukocyte reactions.
Mixed leukocyte reaction. MoDCs were incubated with previously labeled T cells (Cell Proliferation Dye eFluor 
450, ThermoFisher, Waltham, MA), in a proportion of 1 DC to 10 T cells (1 × 105 T cells per well) in triplicates. T 
cells were isolated from PBMCs from healthy donors using the Pan T cell isolation kit according to the manufac-
turer’s protocol (Miltenyi Biotec, Germany). After 5 days, cells were harvested, labeled with anti-CD3, anti-CD4 
and anti-CD8 antibodies and analyzed by flow cytometry, where at least 104 events were acquired per sample.
SiHa spheroids. 5 × 103 SiHa cells were seeded on 1% agarose in U bottom plates and incubated for 4 days.
Tumor cell effects on neutrophils. 3 × 104 circulating neutrophils from healthy donors were seeded on 1% agarose 
in U bottom plates or on 4 days SiHa or HeLa spheroids. At 4, 8 and 24 hours of incubation, we harvested cells to 
count, label with anti-CD16, anti-CD66b and DAPI45, and analyze by flow cytometry, where 3 × 104 events were 
acquired. Supernatants were used for cytokine detection using the Human Inflammatory Cytokine Bead Array 
Kit (BD Biosciences, Carlsbad, CA).
Interaction between neutrophils and T cells in tumor spheroids. Circulating T cells and neutrophils were isolated 
from healthy donors as previously described. Cell Proliferation Dye labeled T cells were stimulated with 1 μg/ml 
ionomycin (SigmaAldrich, St Louis, MO) and 100 ng/ml TPA (or PMA) (Cell Signaling Technology, Danvers, 
MA) for 5 hours, then washed in fresh medium and added to 4 days SiHa spheroids, or neutrophils, or neutrophils 
and incubated with 4 days SiHa spheroids for 5 hours. To mimic the in vivo situation, we added 1 T cell for each 
neutrophil (3 × 104 each) or 10 T cells for each neutrophil in culture. Five days later, cells were harvested and labe-
led with anti-CD4, anti-CD8, anti-CD11b, anti-CD69 and anti-CD25 and analyzed by flow cytometry.
ROS production by neutrophils. 3 × 104 neutrophils isolated from blood samples or biopsies, the last one 
using positive selection with anti-CD15 beads and MS columns (Miltenyi Biotec, Germany) were treated with 
100 ng/ml TPA (Cell Signaling Technology, Danvers, MA) for 15 min in culture, and then incubated with 2 μl 
of Dihydrorhodamine 123, DHR, (ThermoFisher, Waltham, MA) for another 15 min. Cells were immediately 
washed, labeled with anti-CD11b, anti-CD66b and anti-CD45, and analyzed by flow cytometry, where a min-
imum of 5 × 103 events were acquired. As controls, we used non-stimulated neutrophils, and neutrophils not 
labeled with DHR.
HPV genotyping. 150 ng of phenol/chloroform extracted DNA from cervical biopsies were used for PCR 
amplification using PGMY09/11 generic primers46. The amplification products were tested through the Roche 
Linear Array HPV genotyping test (Roche Molecular Diagnostics, Alameda, CA) capable of detecting 37 different 
HPV types.
G-CSF plasma concentration. G-CSF plasma concentrations were determined by ELISA (ThermoFisher, 
Waltham, MA), according to the manufacture’s instructions.
Histology. 4 μm sections from paraffin embedded tissues were processed and stained with HE at the 
Pathology Department of the School of Medicine, Universidade de São Paulo. Images were acquired using an 
Olympus BX61 microscope with attached Olympus camera, and accompanying software for image acquisition. 
Images were not submitted to edition or modification.
Statistical analyses. Results involving comparing more than two experimental groups were tested by 
one-way analysis of variance (ANOVA), followed by Bonferroni pair comparison. Testing between 2 experimental 
groups was performed by t-test or Mann-Whitney test according to normal distribution assumption. Correlation 
between populations or biological parameters was determined by Pearson correlation. Level of significance 
accepted was 5%. All tests were conducted using the SPSS statistical package for Windows v1.8 or Microsoft Excel.
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